Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database
- Metab.-Clin. Exp., 2022 Sep 17;138:155311 | https://doi.org/10.1016/j.metabol.2022.155311
